Overview
Ibrahim Elgabry is a Cardiologist in Woonsocket, Rhode Island. Dr. Elgabry is rated as an Experienced provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Necrosis, Coronary Heart Disease, Peripheral Artery Disease, and Arterial Insufficiency.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
191 Social St Ste 100, Woonsocket, RI 02895
14 Prospect St, Milford, MA 01757
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Women's Hospital, Heart And Vascular Center
Dr. Pinak Bipin Shah is director of the Cardiac Catheterization Laboratory at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also an associate professor of medicine at Harvard Medical School.He received his medical degree from Perelman School of Medicine at the University of Pennsylvania. He completed an internal medicine residency at BWH and served as chief medical resident. He then completed fellowships in cardiovascular disease, interventional cardiology and cardiovascular clinical biometrics at BWH. He is board certified in cardiovascular disease and interventional cardiology.Dr. Shah’s clinical interests include catheterization based techniques for the treatment of complex valvular and structural heart disease as well as complex coronary intervention. Dr. Shah’s practice focuses on trans-catheter aortic valve replacement (TAVR), mitral valve interventions, PFO/ASD closure, alcohol septal ablation for hypertrophic cardiomyopathy, and high-risk percutaneous coronary intervention (PCI) cases. Dr. Shah has received research funding from the Massachusetts Department of Public Health and National Heart, Lung and Blood Institute. He has also been listed one of America’s Top Doctors by Castle Connolly. Dr. Shah is rated as an Elite provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Mitral Stenosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).
Massachusetts General Hospital
Jonathan Passeri is a Cardiologist in Boston, Massachusetts. Dr. Passeri is rated as a Distinguished provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Heart Failure with Preserved Ejection Fraction (HFpEF), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).
Brigham And Women's Hospital, Heart And Vascular Center
Patrick T. O'Gara, MD, is the Director of Strategic Planning for the Cardiovascular Division at Brigham and Women’s Hospital, the Watkins Family Distinguished Chair in Cardiology and Professor of Medicine at Harvard Medical School. His clinical activities are focused on patients with valvular heart disease, other structural heart diseases and aortic diseases, although he also maintains a large practice of general cardiology. Since 2001, he has been named annually among the Top Doctors in Boston and the U.S.O'Gara served as President of the American College of Cardiology (ACC) in 2014-15. Additional ACC leadership positions include his roles as Co-Chair of the ACC 2012 Scientific Session program committee, co-directorship of the ACC Board Review Course for Certification and Recertification, and Editor-in-Chief of the ACC Self-Assessment Program (ACCSAP). He served as Chair of the American Heart Association's (AHA's) Council on Clinical Cardiology from 2003-2005 and as the inaugural Editor of Heart Insight magazine from 2006 to 2011. In 2011, he received the Paul Dudley White Award from the Boston Division of the AHA Founder's Affiliate and has also been recognized with the Laennec Master Clinician Award (2011) and the Laennec Clinician Educator Award (2012). O'Gara was Chair of the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated in several other guideline, expert consensus, scientific advisory and appropriate use criteria writing groups.He is currently the Vice-Chair for the AHA/ACC Task Force on Clinical Practice Guidelines. He is also the Steering Committee Co-Chair of the National Heart, Lung, and Blood Institute's Cardiothoracic Surgery Network, which has completed 3 groundbreaking, randomized controlled trials in cardiac surgery. O’Gara serves as Associate Editor for JAMA Cardiology and is a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He has lectured widely and authored or co-authored over 250 original manuscripts, chapters, critical reviews, statements and editorials. Dr. O'gara is rated as a Distinguished provider by MediFind in the treatment of Aortic Valve Stenosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Bicuspid Aortic Valve, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Coronary Heart DiseaseDr. Elgabry isDistinguished. Learn about Coronary Heart Disease.
- NecrosisDr. Elgabry isDistinguished. Learn about Necrosis.
- Advanced
- AnginaDr. Elgabry isAdvanced. Learn about Angina.
- ApoplexyDr. Elgabry isAdvanced. Learn about Apoplexy.
- Arterial EmbolismDr. Elgabry isAdvanced. Learn about Arterial Embolism.
- Arterial InsufficiencyDr. Elgabry isAdvanced. Learn about Arterial Insufficiency.
- AtherosclerosisDr. Elgabry isAdvanced. Learn about Atherosclerosis.
- Atrial FibrillationDr. Elgabry isAdvanced. Learn about Atrial Fibrillation.
- Experienced
- Acute Coronary SyndromeDr. Elgabry isExperienced. Learn about Acute Coronary Syndrome.
- Aortic RegurgitationDr. Elgabry isExperienced. Learn about Aortic Regurgitation.
- Aortic Valve StenosisDr. Elgabry isExperienced. Learn about Aortic Valve Stenosis.
- ArrhythmiasDr. Elgabry isExperienced. Learn about Arrhythmias.
- Atrial TachycardiaDr. Elgabry isExperienced. Learn about Atrial Tachycardia.
- Atrioventricular Nodal Reentrant Tachycardia (AVNRT)